Medical Properties Trust Inc
MPTNYSECIK 1287865Real estateFiscal year ends Dec 31
Reports and events: 331 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1017:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-342713 |
| 2026-08-1016:52 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342583 |
| 2026-08-1009:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-341434 |
| 2026-06-0116:55 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-251659 |
| 2026-05-0816:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-214700 |
| 2026-04-3008:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-194165 |
| 2026-04-1316:36 ET | DEF 14A | Proxy statementPeriod 2026-04-13 | 0001193125-26-152971 |
| 2026-02-2608:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-073587 |
| 2026-02-1908:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-058167 |
| 2026-01-2008:56 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-016037 |
| 2025-11-0716:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272324 |
| 2025-10-3008:36 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-257549 |
| 2025-08-1416:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-180805 |
| 2025-08-1117:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-178048 |
| 2025-08-0817:25 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106022 |
| 2025-07-3108:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-170123 |
| 2025-06-0316:59 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-134173 |
| 2025-05-0917:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-068203 |
| 2025-05-0108:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-109039 |
| 2025-04-1716:30 ET | DEF 14A | Proxy statementPeriod 2025-04-17 | 0000950170-25-055431 |
| 2025-03-0317:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-030989 |
| 2025-02-2708:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-037671 |
| 2025-02-1817:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-028746 |
| 2025-01-3117:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-018490 |
| 2025-01-2909:22 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-015022 |
| 2024-11-1317:09 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-09-30 | 0000950170-24-126476 |
| 2024-11-1217:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125623 |
| 2024-11-0708:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-252717 |
| 2024-09-1717:22 ET | 8-K | 1.02 Termination of a material agreement; 2.06 Material impairments; 9.01 Financial statements and exhibits | 0001193125-24-220733 |
| 2024-08-0917:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094888 |
| 2024-08-0808:38 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-196518 |
| 2024-06-0316:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-153035 |
| 2024-05-2916:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-065929 |
| 2024-05-2916:06 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-149138 |
| 2024-05-2821:52 ET | 8-K | 2.03 New direct financial obligation | 0001193125-24-147330 |
| 2024-05-1616:48 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-140662 |
| 2024-05-1017:31 ET | 8-K | 2.06 Material impairments | 0001193125-24-136307 |
| 2024-05-0909:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134847 |
| 2024-05-0717:21 ET | 8-K | 8.01 Other events | 0001193125-24-133302 |
| 2024-04-1817:30 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-100968 |
| 2024-04-1717:01 ET | DEF 14A | Proxy statementPeriod 2024-05-30 | 0001193125-24-099222 |
| 2024-03-1417:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-068020 |
| 2024-02-2917:08 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023248 |
| 2024-02-2109:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-040842 |
| 2024-01-0519:42 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-002655 |
| 2023-12-1416:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-295523 |
| 2023-11-0916:41 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062169 |
| 2023-10-2609:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-263599 |
| 2023-08-0917:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040734 |
| 2023-08-0808:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-205633 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:19 ET. Listed shows no prices and gives no investment advice.